Ellsworth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-105,067
Closed -$3.02M 194
2023
Q4
$3.02M Buy
105,067
+4,455
+4% +$135K 0.96% 44
2023
Q3
$3.14M Buy
100,612
+1,981
+2% +$70.1K 1.11% 43
2023
Q2
$3.62M Buy
98,631
+4,697
+5% +$183K 1.25% 40
2023
Q1
$3.83M Sell
93,934
-1,417
-1% -$61.2K 1.35% 32
2022
Q4
$4.29M Buy
95,351
+7,985
+9% +$383K 1.61% 13
2022
Q3
$3.82M Buy
87,366
+3,195
+4% +$155K 1.64% 15
2022
Q2
$4.41M Buy
84,171
+2,379
+3% +$121K 1.78% 10
2022
Q1
$4.07M Buy
81,792
+12,400
+18% +$643K 1.44% 24
2021
Q4
$4.1M Buy
69,392
+10,868
+19% +$538K 1.52% 15
2021
Q3
$2.52M Buy
58,524
+14,740
+34% +$653K 1.15% 38
2021
Q2
$1.72M Buy
43,784
+7,298
+20% +$284K 0.84% 50
2021
Q1
$1.32M Buy
36,486
+8,195
+29% +$291K 0.8% 52
2020
Q4
$1.04M Buy
28,291
+3,648
+15% +$134K 0.75% 54
2020
Q3
$858K Sell
24,643
-173
-0.7% -$6.07K 0.86% 50
2020
Q2
$770K Buy
+24,816
New +$843K 0.84% 49

Other funds holding PFE